DEXTROSE ORAL GEL

The Defense Logistics Agency awarded a delivery order under contract SPE2DX-25-D-9900 to DMS PHARMACEUTICAL GROUP INC, identified by CAGE code 1UNB0, for the procurement of 10,000 pints of DEXTROSE ORAL GEL with NSN 6505014253168 at a total contract value of $100.70. The award was issued on July 18, 2026, with a delivery deadline of July 20, 2026, under a firm fixed price structure consistent with standard DLA medical supply orders. The item is to be shipped FOB destination to USS JOHN P MURTHA (LPD 26) at FPO AP 96694, with the contractor responsible for all transportation costs and risks until delivery. Shipment must be made via the fastest traceable means, explicitly excluding parcel post, and must comply with VSM (Vendor Shipment Module) requirements. No quantity variance is permitted, and medical substitution is allowed under RANK 01-00574006930. Inspection and acceptance occur upon arrival at the delivery point, conducted by an authorized government representative, with no specific MIL-STD packaging or marking standards cited beyond required identifiers like NSN, CAGE codes, and part numbers. Invoicing must follow DFARS 252.232-7003, implying electronic submission through WAWF. The awardee is certified as a small business, with no additional socioeconomic designations indicated. The contracting officer is Lisa Quinn, and Shairy M. Cartagena serves as the administrative contact, with payment to be processed through DEF FIN AND ACCOUNTING SVC, P.O. Box 182317, Columbus, OH. The contract references DLAD PROC NOTE C19/C20 for administrative compliance but does not include standardized FAR or DFARS clauses in the delivery order documentation.